nav-left cat-right
cat-right

DiscoveryBioMed, Inc. Awarded Phase 2 SBIR Grant b...

BIRMINGHAM, Ala.–(BUSINESS WIRE)–DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and ...

Clinical Trials in Asia Summit 2009

4th Annual Pharmacovigilance Conference Determining the prospective strategies for Implementing Clinical trials in India & South Asia – Today’s Hottest Market 18th – 20th May 2009, The Park, New Delhi, India   Key Speakers • Chandrashekhar Potkar, Director, Medical and Regulatory Affairs, Pfizer, India • Viraj Rajadhyaksha, Senior Manager, Operations, Planning & Mgmt...

Plexxikon Receives Key Patents on Novel Compounds ...

BERKELEY, Calif.–(BUSINESS WIRE)–Plexxikon Inc. today announced the issuance of key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-Based Drug Discoveryâ„¢ platform. Plexxikon’s pipeline of preclinical and clinical stage product opportunities currently span potential treatments for cardio-renal disease, CNS disorders, ...

GTCbio Announces 4th Annual Assay Development and ...

San Francisco, CA – GTCbio Announces its 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009. As compounds derived from high throughput screening increasingly find their way into clinical trials, drug screening has become widely accepted as a critical step in the drug discovery process. After more than a decade of rapid growth, tremendous progress has been made in assay technology,...

EPA Presents Initial Results from Caliper Life Sci...

HOPKINTON, Mass., March 19 /PRNewswire-FirstCall/ — Caliper Life Sciences, Inc. (NASDAQ: CALP) , a leading provider of tools and services for drug discovery and life sciences research, today announced that the United States Environmental Protection Agency (EPA) presented initial analyses of Phase I data generated by Caliper Discovery Alliances and Services (CDAS) under the EPA’s ToxCast(TM) screening program at...

Plexxikon Receives Key Patents on Novel Compounds ...

BERKELEY, Calif.–(BUSINESS WIRE)–Plexxikon Inc. today announced the issuance of key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-Based Drug Discoveryâ„¢ platform. Plexxikon’s pipeline of preclinical and clinical stage product opportunities currently span potential treatments for cardio-renal disease, CNS disorders, ...
Page 5 of 8« First...34567...Last »